Stratasys target raised to $140 at Brean Capita
Brean Capital raises their SSYS tgt to $140 from $130. Specifically, the firm believes the most important current "call" on DDD stock is organic growth viability of the core professional non-metals market. If that growth can be 25%+, then DDD (and SSYS) remain attractive stocks at these levels in their view, and if it isn't, then valuation becomes tougher to justify. SSYS Jun Q results and L-T organic growth outlook of 25%+ would be positive in this regard.